Learn About Breztri, the New Triple-Therapy Inhaler for Severe COPD

November 2022

Breztri Aerosphere will be the latest “3-in-1” inhaler for COPD.

It contains the inhaled corticosteroid (ICS) budesonide...the long-acting muscarinic antagonist (LAMA) glycopyrronium...and the long-acting beta-agonist (LABA) formoterol

Breztri is the second ICS/LAMA/LABA combo for COPD after Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Immunizations Prevent Errors With COVID-19 Boosters and Flu Vaccinations
COPD Learn About Breztri, the New Triple-Therapy Inhaler for Severe COPD
Contraceptives Clear Up Confusion About Emergency Contraception
Anticoagulants Know When to Rely on Warfarin Instead of a DOAC
Pediatrics Be Familiar With the Role of Statins in Children
Med Safety Watch for Gallbladder Problems in Patients on GLP-1 Agonists
Hormone Therapy Answer FAQs About Menopausal Hormone Therapy
Cardiology Match the Choice of Calcium Channel Blocker to Your Patient
Infectious Diseases Don’t Jump to Antibiotics for Acute Infectious Diarrhea

Learn About Breztri, the New Triple-Therapy Inhaler for Severe COPD

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents